AlphAIalphai — Financial news for AI agents
financialcontent.comJUL 283 min read$FTRE

Fortrea Earnings: What To Look For From FTRE

Fortrea Holdings (FTRE) is set to report earnings Wednesday. Last quarter it posted revenue of $636.5M, down 2.3% YoY, and beat analysts on EPS and full-year EBITDA guidance. This quarter, analysts expect revenue down 8.8% YoY. FTRE is up 9.2% over a month; average analyst price target is $17.25 versus $19.13.

Original reporting
financialcontent.com
Published Jul 28, 2026, 5:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 5:51 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Fortrea Earnings: What To Look For From FTRE — source image
Source · financialcontent.com
Decision brief

The 30-second read

$FTRENeutralMed
01

Why it matters

Traders can frame the earnings risk around whether the company can avoid another revenue miss and whether EBITDA guidance remains credible given consensus expects revenue to fall 8.8% YoY.

02

Market read

The article is primarily a pre-earnings checklist for FTRE, anchored to consensus revenue expectations and peer performance context.

03

What to watch

The article does not quantify margin, cash flow, backlog, or guidance details for this quarter, which could dominate the stock reaction versus the headline revenue YoY rate.

Relevance 4/10Novelty 4/10Timing: ahead of Fortrea earnings this Wednesday morning

Background

Fortrea beat revenue and EPS expectations last quarter and topped full-year EBITDA guidance, but has missed revenue estimates multiple times over the last two years.

Company-level read

Ticker impact

$FTRENeutralMedium confidence
Context

Fortrea is set to report earnings Wednesday, with the article citing consensus expecting an 8.8% YoY revenue decline and recent estimate reconfirmations.

Expected impact

Near-term volatility likely around the earnings release, with upside skew if revenue decline is smaller than the 8.8% expectation and EBITDA guidance holds.

Evidence & confidence

The text provides specific consensus expectations (8.8% YoY revenue decline) and notes a history of missing revenue estimates, which can drive positioning into the print.

Market effects

Sector

Uses peer results (Medpace, West Pharmaceutical Services) as a read-across for life sciences tools and services demand trends.

Regional

No specific regional market impact is disclosed.

Global

No explicit global macro or cross-border catalyst is disclosed.

Counterpoint

What could challenge this read

The peer read-across may not translate to Fortrea if its client mix or study pipeline differs materially, so the 8.8% YoY revenue decline expectation could be a poor proxy.

Key entities

  • public_company
    Fortrea Holdings

    NASDAQ-listed clinical research company scheduled to report earnings Wednesday morning.

  • public_company
    Medpace

    Peer cited as having delivered YoY revenue growth and a post-results stock move.

  • public_company
    West Pharmaceutical Services

    Peer cited as having topped revenue estimates with a negative post-results move.

Read at source← All news

Related articles

JUL 30
$FTREHighAI 9/10

Fortrea Q2 Earnings Call Highlights

"The environment has become more supportive, but our results are not simply the result of market recovery," Thakral said, attributing the performance to changes in commercial execution, including improved global coordination, a sharper focus on opportunities where the company can compete effectively and a clearer approach to serving distinct customer segments. Thakral said Fortrea's clinical pharmacology services business was a particular area of strength.

yahoo.com6 min
JUL 29
$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full

Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2026 revenue of $678.2 million, down 4.5% year over year but 4.7% above market expectations, according to the company. Full-year revenue guidance was $2.66 billion at the midpoint, 1.8% above analysts’ estimates. Non-GAAP EPS was $0.23, 27.2% above consensus.

financialcontent.com4 min
JUL 29
$FTREMed

Fortrea Holdings Inc. (FTRE): Results of Operations and Financial Condition

Fortrea Holdings Inc. (FTRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-pressreleasedat.htm EX-99.1 Document Exhibit 99.1 Fortrea Reports Second Quarter 2026 Results Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended J

SEC EDGAR 8-K4 min
JUN 4
$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Trading 10.5% Higher – Should You Buy?

Fortrea Holdings (NASDAQ:FTRE) rose 10.5% in mid-day trading Thursday, reaching $17.20 and last at $17.27, after closing at $15.63. Volume was 886,991 shares, down 42% vs. average. Analysts cited include price targets from $14 to $20. On May 5, Fortrea reported $0.16 EPS vs $0.03 expected and $636.5M revenue vs $628.5M.

dailypolitical.com5 min
JUN 4
$FTREMed

Fortrea (NASDAQ:FTRE) Trading 10.5% Higher – Should You Buy?

Fortrea Holdings (FTRE) rose 10.5% mid-day Thursday, trading between $17.20 and $17.27 after closing at $15.63. Volume was 886,991 shares, down 42% from average. Analysts cited include Mizuho (neutral, $13), Citigroup (buy, $20) and others; consensus is Hold with $17.25 average target. On May 5, Fortrea reported $0.16 EPS and $636.5M revenue.

tickerreport.com5 min